Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
skin sensitisation: in vivo (LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
May 04, 2006 - July 05, 2006
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: GLP guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2006
Report date:
2006

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
Version / remarks:
, 2002
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
Version / remarks:
, 2004
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Remarks:
signed 2005-11-21
Type of study:
mouse local lymph node assay (LLNA)

Test material

Constituent 1
Chemical structure
Reference substance name:
-
EC Number:
486-080-1
EC Name:
-
Cas Number:
924626-15-3
Molecular formula:
C20H20O3
IUPAC Name:
Reaction mass of (2E)-2-Benylidene-5,6-dimethoxy-3,3-dimethylindan-1-one and (2Z)-2-Benylidene-5,6-dimethoxy-3,3-dimethylindan-1-one
Details on test material:
Name: BIO 1031/1
Substance type: pure active substance
Physical state: solid
Storage condition of test material: ambient temp., dark, dry, in original container

In vivo test system

Test animals

Species:
mouse
Strain:
CBA
Sex:
female
Details on test animals and environmental conditions:
TEST ANIMALS
- Source: Mice were supplied by Charles River UK limited. The animals were nulliparous and non-pregnant.
- Age at study initiation: 8-12 weeks
- Weight at study initiation: 15-23 g
- Housing: The animals were individually housed in suspended solid-floor polypropylene cages furnished with softwood woodflakes.
- Diet: Certified Rat and Mouse Diet (Code 5LF2) supplied by BCM IPS Limited, London, UK; ad libitum
- Water: ad libitum
- Acclimation period: at least 5 days


ENVIRONMENTAL CONDITIONS
- Temperature: 19-25 °C
- Humidity: 30-70 %
- Air changes: 15 per hour
- Photoperiod: 12 hours light/dark cycle
TEST ANIMALS
- Source: Mice were supplied by Charles River UK limited. The animals were nulliparous and non-pregnant.
- Age at study initiation: 8-12 weeks
- Weight at study initiation: 15-23 g
- Housing: The animals were individually housed in suspended solid-floor polypropylene cages furnished with softwood woodflakes.
- Diet: Certified Rat and Mouse Diet (Code 5LF2) supplied by BCM IPS Limited, London, UK; ad libitum
- Water: ad libitum
- Acclimation period: at least 5 days


ENVIRONMENTAL CONDITIONS
- Temperature: 19-25 °C
- Humidity: 30-70 %
- Air changes: 15 per hour
- Photoperiod: 12 hours light/dark cycle

Study design: in vivo (LLNA)

Vehicle:
acetone/olive oil (4:1 v/v)
Concentration:
Animals were treated with the test material at concentrations of 5%, 10% or 25% (w/w) in acetone/olive oil 4:1.
No. of animals per dose:
4 mice in the treatment group and 4 mice served as the control
Details on study design:
RANGE FINDING TESTS: As no toxicological information was available regarding the sysemic toxicity/irritancy potential of the test material a preliminary screening test was performed using 1 mouse. The mouse was treated by daily application of 25µl of the test material at a concentration of 25% w/w in acetone/olive oil 4:1, to the dorsal surface of each ear for 3 consecutive days. The mouse was observed twice daily an Days 1, 2 and 3 and once on Days 4, 5 and 6. Any signs of toxicity or excessive local irritaion noted during this period were recorded. The bodyweight of the mouse was recorded on Day 1 and on Day 6.

MAIN STUDY
TREATMENT PREPARATION AND ADMINISTRATION:
The mice were treated by daily application of 25µl of the appropirate concentration of the test material to the dorsal surface of each ear for 3 consecutive days. The teat material formulation was administered using an automatic micropipette and spread over the dorsal surface of the ear using the tip of the pipette.
A further goup of 4 mice received the vehicle alone in the same manner.

[3H]-METHYL THYMIDINE ADMINSTRATION: 5 days following the first topical application of the test material (Day 6) all mice were injected via the tail vein with 250µl of phosphate buffered saline (PBS) containing [3H]-methyl thymidine giving a total of 20 µCi to each mouse.

CLINICAL OBSERVATIONS: All animals were observed twice daily on Days 1, 2 and 3 and on a daily basis on Days 4, 5 and 6. Any signs of toxicity or signs of ill health during the test were recorded.

BODYWEIGHTS: The bodyweight of each mouse was recorded on Day 1 and Day 6.

TERMINATION: 5 hours following the administration of [3H]-methyl thymidine all mice were killed by carbon dioxide asphyxiation. The draining auricular lymph nodes from the 4 mice were excised and pooled for each experimental group. For each group 1 ml of PBS was added to the pooled lymph nodes.

PREPARATION OF SINGLE CELL SUSPENSION: A single cell suspension of pooled lymph node cells was prepared by gentle mechanical disaggregation through a 200-mesh stainless steel gauze. The lymph node cells were rinsed through the gauze with 4ml of PBS into a labelled petri dish. The lymph node cell suspension was centrifuged at 1400 rpm for 10 minutes. To precipitate out the radioactive material, the pellet was resuspended in 3ml of 5% trichloroacetic acid (TCA).

DETERMINATION OF THE [3H]-METHYL THYMIDINE INCORPORATION: [3H]-methyl thymidine incorporation was measured by beta-scintillation counting.

INTERPRETATION OF THE RESULTS: The proliferation response of lymph node cells was expressed as the number of radioactive disintegrations per minute per lymph node and as the ratio of [3H]-methyl thymidine incorporation into lymph node cells of test nodes relative to that recorded for the control nodes. The test material will be regarded as a sensitiser if at least one concentration of the test material results in a threefold or greater increase in [3H]-methyl thymidine incorporation compared to control values.
Positive control substance(s):
hexyl cinnamic aldehyde (CAS No 101-86-0)
Statistics:
not applicable

Results and discussion

Positive control results:
5 % (w/w) Stimulation index (SI): 2.50 Result: negative
10 % (w/w) Stimulation index (SI): 4.03 Result: positive
25 % (w/w) Stimulation index (SI): 9.13 Result: positive

In vivo (LLNA)

Resultsopen allclose all
Parameter:
SI
Remarks on result:
other: 5 % (w/w) SI: 0.83 10 % (w/w) SI: 0.83 25 % (w/w) SI: 0.83
Parameter:
other: disintegrations per minute (DPM)
Remarks on result:
other: 5 % (w/w) DPM: 10937.99 10 % (w/w) DPM: 10935.69 25 % (w/w) DPM: 10893.52

Any other information on results incl. tables

PRELIMINARY SCREENING TEST: No signs of systemic toxicity were noted. Pale yellow-cloured residual test material was noted on the ear and fur 1 hour post dosing on Day 3. Based on this information the dose levels selected for the main test were 5%, 10% and 25% w/w in vehicle.

MAIN TEST:

CLINICAL OBSERVATIONS AND MORTALITY DATA: There were no deaths. Pale yellow-coloured residual test material was noted on the ears and fur on the animals treated with the test material at a concentration of 25% w/w in vehicle 1 hour post dosing on Days 2 and 3. No signs of systemic toxicity were noted in the test or control groups.

BODYWEIGHT: Bodyweight changes of the test animals between Day 1 and 6 were comparable to those observed in the corresponding control group animals.

The test material was considered to be a non-sensitiser under the conditions of the test.

Table 1: DPM, DPM/node and stimulation index (SI)

Concentration

(% w/w) in acetone/olive oil 4:1

DPM

DPM/nodea

Stimulation index (SI)b

Result

Vehicle

13102.33

1637.79

N/A

N/A

5

10937.99

1367.25

0.83

negative

10

10935.69

1366.96

0.83

negative

25

10893.52

1361.69

0.83

negative

a = DPM/node obtained by dividing the DPM value by 8 (total number of lymph nodes); b = stimulation index of 3.0 or greater indicates a positive result; N/A not applicable

Applicant's summary and conclusion

Interpretation of results:
not sensitising
Remarks:
Migrated information
Conclusions:
The test material was considered to be a non-sensitiser under the conditions of the test.